tiprankstipranks
Advertisement
Advertisement

C.E.Management Integrated Laboratory Delivers Strong 2025 Results, Guides for Moderate Growth in 2026

Story Highlights
  • C.E.Management Integrated Laboratory posted higher 2025 sales, profits and per-share earnings, while keeping dividends stable and strengthening its already solid financial position.
  • For 2026 the company projects further revenue growth but a modest profit decline, reflecting margin pressure even as it maintains its dividend policy and operational continuity.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
C.E.Management Integrated Laboratory Delivers Strong 2025 Results, Guides for Moderate Growth in 2026

Claim 55% Off TipRanks

C.E.Management Integrated Laboratory Co., Ltd. ( (JP:6171) ) has provided an update.

C.E.Management Integrated Laboratory reported steady growth for the year ended December 31, 2025, with net sales rising 4.8% to ¥7.70 billion and operating profit climbing 15.3%, while profit attributable to owners of parent jumped 33.2%, lifting earnings per share to ¥33.96. The balance sheet remained robust, with total assets of ¥7.35 billion, an equity ratio of 70.4% and stable cash levels, and the company maintained its annual dividend at ¥12 per share, implying a lower payout ratio as profitability improved.

For 2026, the company forecasts a further 4.0% increase in full-year net sales to ¥8.0 billion and modest operating profit growth, but expects profit attributable to owners of parent to decline 6.0%, signaling some pressure on bottom-line margins despite top-line expansion. Management introduced changes in accounting policies due to revised standards yet kept the consolidation scope unchanged, suggesting continuity in operations, while dividend guidance indicates an ongoing commitment to shareholder returns even as earnings are projected to soften slightly.

The most recent analyst rating on (JP:6171) stock is a Buy with a Yen567.00 price target. To see the full list of analyst forecasts on C.E.Management Integrated Laboratory Co., Ltd. stock, see the JP:6171 Stock Forecast page.

More about C.E.Management Integrated Laboratory Co., Ltd.

C.E.Management Integrated Laboratory Co., Ltd., listed on the Tokyo Stock Exchange under code 6171, operates in Japan’s testing and laboratory services sector. The company focuses on integrated laboratory and related intellectual property services, targeting corporate clients that require specialized testing, analysis and strategic IP support across various industries.

Average Trading Volume: 81,320

Technical Sentiment Signal: Strong Buy

Current Market Cap: Yen6.29B

For a thorough assessment of 6171 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1